Dr. Kim S Frederickson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 Professional Center Drive, Suite 414 Novato Dermatology Associates, Novato, CA 94947 Phone: 415-892-0754 Fax: 415-897-3204 |
Stephen Lewis Dalton, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 400 Professional Center Dr, Suite 414, Novato, CA 94947 Phone: 415-892-0754 Fax: 415-897-3204 |
News Archive
The 5th German Spine Congress (5. Jahrestagung der Deutschen Wirbelsaulengesellschaft (DWG)) will take place from 16 to 18 December 2010 at the Congress Centre in Bremen. joimax(R) is proud to present the innovative HD 5-in-1 complete system at their booth no.20: The C-Camsource(R)HD Twister offers state-of-the-art HD technology and works with both the joimax(R) HD endoscopes and HD flat screens producing an extremely precise and sharp picture and video imaging for endoscopic spinal surgery.
A new 'closed-loop' system can precisely adjust levels of anesthetics and analgesic drugs in patients undergoing surgery, reports a study in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Cobalt Pharmaceuticals has received a Notice of Compliance from Health Canada to market Atorvastatin Calcium Tablets in the 10, 20, 40 and 80 mg strengths. Watson has initiated shipments of this product.
Thomas Jefferson University has started recruiting patients for a new National Cancer Institute-sponsored clinical trial to test whether the cholesterol-reducing drug rosuvastatin is effective in the prevention of recurrent colon cancer.
Ferring Pharmaceuticals Inc. today announced publication of one of its pivotal Phase 3 trials of LYSTEDA (tranexamic acid) tablets for cyclic heavy menstrual bleeding in the October issue of the peer-reviewed journal, Obstetrics & Gynecology. The six-month clinical trial demonstrated that LYSTEDA significantly reduced menstrual blood loss from baseline, and improved health-related quality-of-life parameters in women with cyclic HMB while maintaining safety and tolerability.
› Verified 5 days ago